NCT04317495

Brief Summary

Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for MDD, but the overall effect sized of the treatment is equivalent to antidepressant pharmacotherapy, and responses are highly variable. Given that rTMS is usually given to patients who have failed pharmacotherapy, a more effective alternative is needed. Therefore, this study will combine computerized cognitive training (CCT) during standard rTMS treatments and assess its feasibility, tolerability, and changes in cognitive control performance and depression symptoms. Participants that agree to the study and meet eligibility will receive standard rTMS (generally 25-36 daily treatments) along with CCT (starting on day 5 of treatment until the pre-taper treatment). In addition, to CCT participants will be asked to complete assessments before and after treatment

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable major-depressive-disorder

Timeline
Completed

Started Aug 2019

Shorter than P25 for not_applicable major-depressive-disorder

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 27, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 19, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 23, 2020

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

1.6 years

First QC Date

March 19, 2020

Last Update Submit

April 5, 2021

Conditions

Keywords

transcranial magnetic stimulationcomputerized cognitive training

Outcome Measures

Primary Outcomes (1)

  • Feasibility assessed by percentage of CCT sessions completed during rTMS

    Percentage CCT sessions completed: (number of sessions completed/number of sessions assigned) X 100

    approximately 30 days (usually 20-30 sessions)

Secondary Outcomes (3)

  • Time on task during treatment

    For each day: 45 min; for entire treatment: approx 30 days

  • Acceptability of CCT

    through study completion date, up to 2 years

  • Cognitive Control Performance change over course of treatment

    Approximately 30 days (usually 20-30 sessions)

Study Arms (1)

Computerized Cognitive Training (CCT)

EXPERIMENTAL

The patients will receive CCT during their standard rTMS treatments (after having 5 days of treatment until the pre-taper treatment).

Other: Computerized Cognitive Training (CCT)

Interventions

After having four rTMS sessions without CCT, the patients will perform CCT (starting day 5) during the rTMS session, which typically last from 20-40 minutes. A course of rTMS therapy includes from 25-36 treatments, given daily, until the last 5-6 treatments, given as a 'taper' over 2 weeks. CCT will be paired with rTMS up until the taper begins. In addition, they will have assessments prior to and after the therapy.

Computerized Cognitive Training (CCT)

Eligibility Criteria

Age18 Years - 99 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of major depressive disorder
  • Eligible to receive and recommended for rTMS for depression
  • Willingness to complete computerized cognitive training and undergo brain stimulation procedures
  • Must be enrolled as a Michigan Medicine patient and currently receiving TMS treatment as part of your clinical care.

You may not qualify if:

  • History of serious neurological illness or brain injury (e.g., stroke)
  • Poor visual acuity impairing performance on the computerized tasks (eyeglasses must be removed for rTMS treatment, but contacts are permissible)
  • Diagnosed intellectual disability
  • Inability to manipulate a tablet device while seated in the rTMS chair

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Conditions

Depressive Disorder, Major

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental Disorders

Study Officials

  • Stephan Taylor, MD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry

Study Record Dates

First Submitted

March 19, 2020

First Posted

March 23, 2020

Study Start

August 27, 2019

Primary Completion

April 1, 2021

Study Completion

April 1, 2021

Last Updated

April 8, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

Locations